Novel Approaches in the Treatment of Dyslipidaemia and T2DM
2 months ago
Recently, Dr Peter Lin of the Canadian Heart Research Centre spoke on treatment strategies in the management of dyslipidaemia and T2DM at an AstraZeneca-sponsored continuing medical education event. Highlights of his presentations are summarized below.
Related MIMS Drugs